“Angular” spirocyclic azetidines: synthesis, characterization, and evaluation in drug discovery

DOI: 10.14469/hpc/13611 Metadata

Created: 2024-01-14 14:05

Last modified: 2024-12-03 08:29

Author: Henry Rzepa

License: Creative Commons: Public Domain Dedication 1.0

Funding: (none given)

Co-author: Pavel Mykhailiuk

Description

The previously neglected “angular” spirocyclic azetidines have been synthesized, characterized, and validated in drug discovery. We have shown that these compounds could act as bioisosteres for common saturated six-membered heterocycles. Their incorporation into the structure of the anticancer drug Sonidegib (instead of morpholine), and Danofloxacine (instead of piperazine) provided novel patent-free analogs with similar physicochemical properties and high activity.

Members

DOIDescription
10.14469/hpc/13647 Spirocyclic-azetidines, R = COEt
10.14469/hpc/13644 Spirocyclic azetidines, R = Me
10.14469/hpc/13645 Spirocyclic-azetidines, R = t-Butyl
10.14469/hpc/13625 Chlorosulfonyl isocyanate, G = -1177.111803
10.14469/hpc/13664 Spirocyclic azetidines, R = Trifluoromethyl
10.14469/hpc/13681 FAIR Data Table. Activation energies and Geometries for“Angular” spirocyclic azetidines: synthesis, characterization, and evaluation in drug discovery.
10.14469/hpc/14602 “Angular” spirocyclic azetidines: synthesis, characterization, and evaluation in drug discovery. Dispersion contributions
10.14469/hpc/13691 Spirocyclic-azetidines, R = CO2Et
10.14469/hpc/13646 Spirocyclic-azetidines, R = OCH2Ph (Benzyl)

Associated DOIs

Current dataset ...DOIDescription
References 10.1002/anie.202418850 Published article: “Angular” Spirocyclic Azetidines: Synthesis, Characterization, and Evaluation in Drug Discovery
isReferencedBy 10.1002/anie.202418850 Published article: “Angular” Spirocyclic Azetidines: Synthesis, Characterization, and Evaluation in Drug Discovery

Edit